Quarterly Outlook
Equity outlook: The high cost of global fragmentation for US portfolios
Charu Chanana
Chief Investment Strategist
FX Trader, Loonieviews.net
Summary: Big pharma is hitting the headlines today after AbbVie Inc (ABBV: NYSE) puckered up, then ponied up $63.0 billion in cash and stock to acquire Botox-maker Allergan (AGN: NYSE).